Status:
COMPLETED
Nurse-led BBTI for Improving Insomnia Severity
Lead Sponsor:
Taipei Medical University
Conditions:
Insomnia
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Brief behavioral treatment for insomnia (BBTI) is a new treatment direction for primary and comorbid insomnia; however, its treatment model has not been established in Taiwan. This study aims to estab...
Detailed Description
Background: Insomnia, defined as difficulty initiating and maintaining sleep such that it interferes with daytime function, is a common complaint among the general population, which in turn undermine ...
Eligibility Criteria
Inclusion
- Report lying awake for ≥30 min a night for ≥3 nights per week for ≥3 months
- Have insomnia with a total score ≥ 8 on the Chinese version of the insomnia severity index (CISI) at screening
- Be able to communicate in Mandarin Chinese
Exclusion
- Premorbid diagnoses of seizure, other sleep disorders (e.g., sleep apnea, screened by using the STOP-Bang questionnaire with a score \> 3), psychiatric diseases, substance abuse, and alcoholism
- Shift workers
- Women who are pregnant, breastfeeding, or in the menopausal transition
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05310136
Start Date
April 1 2022
End Date
July 31 2023
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University
Taipei, Taiwan, 110